Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae
The Journal of Infectious Diseases · 30.07.2025 · 232 (1) · 39-49
DOI: 10.1093/infdis/jiae318 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 25.06.2024. Verfasst von Nusrat J Epsi und 35 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Scienc…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, NIH HHS, Infectious Disease Clinical Research Program.
Abstract (Originalsprache)
Background
Post-COVID conditions (PCC) are difficult to characterize, diagnose, predict, and treat due to overlapping symptoms and poorly understood pathology. Identifying inflammatory profiles may improve clinical prognostication and trial endpoints.
Methods
This analysis included 1988 SARS-CoV-2 positive U.S. Military Health System beneficiaries who had quantitative post–COVID symptom scores. Among participants who reported moderate-to-severe symptoms on surveys collected 6 months post-SARS-CoV-2 infection, principal component analysis followed by k-means clustering identified distinct clusters of symptoms.
Results
Three symptom-based clusters were identified: a sensory cluster (loss of smell and/or taste), a fatigue/difficulty thinking cluster, and a difficulty breathing/exercise intolerance cluster. Individuals within the sensory cluster were all outpatients during their initial COVID-19 presentation. The difficulty breathing cluster had a higher likelihood of obesity and COVID-19 hospitalization than those with no/mild symptoms at 6 months post-infection. Multinomial regression linked early post-infection D-dimer and IL-1RA elevation to fatigue/difficulty thinking and elevated ICAM-1 concentrations to sensory symptoms.
Conclusions
We identified three distinct symptom-based PCC phenotypes with specific clinical risk factors and early post-infection inflammatory predictors. With further validation and characterization, this framework may allow more precise classification of PCC cases and potentially improve the diagnosis, prognostication, and treatment of PCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
- Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Division of Infectious Diseases, Brooke Army Medical Center, San Antonio, Texas, USA.
- Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Division of Infectious Diseases, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
ORCID-Profile: Nusrat J Epsi, Tahaniyat Lalani, Christopher J Colombo, Brian K Agan, Stephanie A Richard
Förderung
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- Infectious Disease Clinical Research Program
- Uniformed Services University of the Health Sciences
- Department of Defense
- NIAID NIH HHS
- Defense Health Program
- National Institutes of Health
Zitieren
APA
Epsi, N. J., Chenoweth, J. G., Blair, P. W., Lindholm, D. A., Ganesan, A., Lalani, T., Smith, A., Mody, R. M., Jones, M. U., Colombo, R. E., Colombo, C. J., Schofield, C., Ewers, E. C., Larson, D. T., Berjohn, C. M., Maves, R. C., Fries, A. C., Chang, D., Wyatt, A., …, & Richard, S. A. (2025). Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae. The Journal of Infectious Diseases, 232(1), 39-49. https://doi.org/10.1093/infdis/jiae318
Vancouver
Epsi NJ, Chenoweth JG, Blair PW, Lindholm DA, Ganesan A, Lalani T, et al. Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae. The Journal of Infectious Diseases. 2025;232(1):39-49. doi:10.1093/infdis/jiae318
BibTeX
@article{Epsi2025,
author = {Epsi, Nusrat J and Chenoweth, Josh G and Blair, Paul W and Lindholm, David A and Ganesan, Anuradha and Lalani, Tahaniyat and Smith, Alfred and Mody, Rupal M and Jones, Milissa U and Colombo, Rhonda E and Colombo, Christopher J and Schofield, Christina and Ewers, Evan C and Larson, Derek T and Berjohn, Catherine M and Maves, Ryan C and Fries, Anthony C and Chang, David and Wyatt, Andrew and Scher, Ann I and Byrne, Celia and Rusiecki, Jennifer and Saunders, David L and Livezey, Jeffrey and Malloy, Allison and Bazan, Samantha and Maldonado, Carlos and Edwards, Margaret Sanchez and Mende, Katrin and Simons, Mark P and O'Connell, Robert J and Tribble, David R and Agan, Brian K and Burgess, Timothy H and Pollett, Simon D and Richard, Stephanie A},
title = {Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {1},
pages = {39--49},
doi = {10.1093/infdis/jiae318}
}
EUVIMED